SolasCure
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2023-07-01attributed |
| Founded | 2015 |
| Headquarters | Cambridge, UK |
| Industry | medtech |
| Stage | unknown |
| Website | solascure.com |
SolasCure develops Aurase Wound Gel, an investigational biologic that debrides chronic wounds while activating repair pathways. It is built for patients with chronic wounds that resist conventional treatment. It shifts from wound maintenance to actively restarting natural healing.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-07-01 | grant | $2.7M | undisclosed |
Detected tech stack
Google Cloud CDN, Four, Sentry, Partytown, Vercel Speed Insights, WebsiteBuilder, Wix, Wix eCommerce, Google Cloud, React, lodash .
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | solascure.com, read 2026-05-08 |
| Description | self-reported | solascure.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.